Fusion Pharmaceuticals Inc. (FUSN)
NASDAQ: FUSN · IEX Real-Time Price · USD
21.51
+0.05 (0.23%)
At close: May 17, 2024, 4:00 PM
21.20
-0.31 (-1.44%)
After-hours: May 17, 2024, 7:51 PM EDT
Fusion Pharmaceuticals Market Cap
Fusion Pharmaceuticals has a market cap or net worth of $1.83 billion as of May 17, 2024. Its market cap has increased by 533.53% in one year.
Market Cap
1.83B
Enterprise Value
1.68B
1-Year Change
533.53%
Ranking
Category
Stock Price
$21.51
Market Cap Chart
Since June 26, 2020, Fusion Pharmaceuticals's market cap has increased from $708.30M to $1.83B, an increase of 158.13%. That is a compound annual growth rate of 27.58%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 17, 2024 | 1.83B | 0.23% |
May 16, 2024 | 1.83B | -0.37% |
May 15, 2024 | 1.83B | 0.52% |
May 14, 2024 | 1.82B | - |
May 13, 2024 | 1.82B | -0.24% |
May 10, 2024 | 1.83B | 0.47% |
May 9, 2024 | 1.82B | -0.09% |
May 8, 2024 | 1.82B | - |
May 7, 2024 | 1.82B | 0.34% |
May 6, 2024 | 1.81B | -0.14% |
May 3, 2024 | 1.82B | -0.18% |
May 2, 2024 | 1.82B | 0.33% |
May 1, 2024 | 1.81B | -0.05% |
Apr 30, 2024 | 1.82B | 0.14% |
Apr 29, 2024 | 1.81B | -0.09% |
Apr 26, 2024 | 1.81B | 0.09% |
Apr 25, 2024 | 1.81B | - |
Apr 24, 2024 | 1.81B | -0.09% |
Apr 23, 2024 | 1.81B | 0.47% |
Apr 22, 2024 | 1.81B | 0.28% |
Apr 19, 2024 | 1.80B | 0.05% |
Apr 18, 2024 | 1.80B | 0.04% |
Apr 17, 2024 | 1.80B | -0.09% |
Apr 16, 2024 | 1.80B | -0.09% |
Apr 15, 2024 | 1.80B | -0.14% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
NeoGenomics | 1.92B |
Sana Biotechnology | 1.91B |
Warby Parker | 1.91B |
Ginkgo Bioworks Holdings | 1.88B |
Protagonist Therapeutics | 1.87B |
Ardelyx | 1.83B |
NewAmsterdam Pharma Company | 1.82B |
Inhibrx | 1.81B |